AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31

Authors: Henlin, JM Boutin, JA Kucharczyk, N Desmet-Beaufort, C Loynel, A Bertrand, M Genton, A Tucker, GC Atassi, G Fauchere, JL
Citation: Jm. Henlin et al., From peptide libraries to optimized nonpeptide ligands in the search for S-farnesyltransferase inhibitors, J PEPT RES, 57(2), 2001, pp. 85-96

Authors: Guilbaud, N Kraus-Berthier, L Meyer-Losic, F Malivet, V Chacun, C Jan, M Tillequin, F Michel, S Koch, M Pfeiffer, B Atassi, G Hickman, J Pierre, A
Citation: N. Guilbaud et al., Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors, CLIN CANC R, 7(8), 2001, pp. 2573-2580

Authors: Melliou, E Magiatis, P Mitaku, S Skaltsounis, AL Pierre, A Atassi, G Renard, P
Citation: E. Melliou et al., 2,2-Dimethyl-2H-anthra[2,3-b]pyran-6,11-diones: A new class of cytotoxic compounds, BIO MED CH, 9(3), 2001, pp. 607-612

Authors: Kostakis, IK Pouli, N Marakos, P Mikros, E Skaltsounis, AL Leonce, S Atassi, G Renard, P
Citation: Ik. Kostakis et al., Synthesis, cytotoxic activity, NMR study and stereochemical effects of some new pyrano[3,2-b]thioxanthen-6-ones and pyrano[2,3-c]thioxanthen-7-ones, BIO MED CH, 9(11), 2001, pp. 2793-2802

Authors: Chollet, AM Le Diguarher, T Murray, L Bertrand, M Tucker, GC Sabatini, M Pierre, A Atassi, G Bonnet, J Casara, P
Citation: Am. Chollet et al., General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors, BIOORG MED, 11(3), 2001, pp. 295-299

Authors: Lisowski, V Enguehard, C Lancelot, JC Caignard, DH Lambel, S Leonce, S Pierre, A Atassi, G Renard, P Rault, S
Citation: V. Lisowski et al., Design, synthesis and antiproliferative activity of tripentones: A new series of antitubulin agents, BIOORG MED, 11(16), 2001, pp. 2205-2208

Authors: Li, Y Shan, F Wu, JM Wu, GS Ding, J Xiao, D Yang, WY Atassi, G Leonce, S Caignard, DH Renard, P
Citation: Y. Li et al., Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle, BIOORG MED, 11(1), 2001, pp. 5-8

Authors: Raoul, M Schaeffer, C Leonce, S Pierre, A Atassi, G Hocquemiller, R Lewin, G
Citation: M. Raoul et al., Synthesis of a novel series of cytotoxic bisindole alkaloids, BIOORG MED, 11(1), 2001, pp. 79-81

Authors: Wu, JM Shan, F Wu, GS Li, Y Ding, J Xiao, D Han, JX Atassi, G Leonce, S Caignard, DH Renard, P
Citation: Jm. Wu et al., Synthesis and cytotoxicity of artemisinin derivatives containing cyanoarylmethyl group, EUR J MED C, 36(5), 2001, pp. 469-479

Authors: Gusman, J Malonne, H Atassi, G
Citation: J. Gusman et al., A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol, CARCINOGENE, 22(8), 2001, pp. 1111-1117

Authors: Leonce, S Perez, V Lambel, S Peyroulan, D Tillequin, F Michel, S Koch, M Pfeiffer, B Atassi, G Hickman, JA Pierre, A
Citation: S. Leonce et al., Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in Sphase leading to apoptosis, MOLEC PHARM, 60(6), 2001, pp. 1383-1391

Authors: Ghirtis, K Pouli, N Marakos, P Skaltsounis, AL Leonce, S Atassi, G Caignard, DH
Citation: K. Ghirtis et al., Design and synthesis of some new pyranoxanthenones with cytotoxic activity, J HETERO CH, 38(1), 2001, pp. 147-152

Authors: Bongui, JB Elomri, A Seguin, E Tillequin, F Pfeiffer, B Renard, P Perre, A Atassi, G
Citation: Jb. Bongui et al., Synthesis and cytotoxic activity of benzophenanthrolinone analogues of acronycine, CHEM PHARM, 49(9), 2001, pp. 1077-1080

Authors: Sittisombut, C Costes, N Michel, S Koch, M Tillequin, F Pfeiffer, B Renard, P Pierre, A Atassi, G
Citation: C. Sittisombut et al., Synthesis and cytotoxic activity of benzopyranoxanthone analogues of benzo[b]acronycine and psorospermine, CHEM PHARM, 49(6), 2001, pp. 675-679

Authors: Malonne, H Farinelle, S Decaestecker, C Gordower, L Fontaine, J Chaminade, F Saucier, JM Atassi, G Kiss, R
Citation: H. Malonne et al., In vitro and in vivo pharmacological characterizations of the antitumor properties of two new olivacine derivatives, S16020-2 and S30972-1, CLIN CANC R, 6(9), 2000, pp. 3774-3782

Authors: Kraus-Berthier, L Jan, M Guilbaud, N Naze, M Pierre, A Atassi, G
Citation: L. Kraus-berthier et al., Histology and sensitivity to anticancer drugs of two human non-small cell lung carcinomas implanted in the pleural cavity of nude mice, CLIN CANC R, 6(1), 2000, pp. 297-304

Authors: Farinelle, S Malonne, H Chaboteaux, C Decaestecker, C Dedecker, R Gras, T Darro, F Fontaine, J Atassi, G Kiss, R
Citation: S. Farinelle et al., Characterization of TNP-470-induced modifications to cell functions in HUVEC and cancer cells, J PHARM TOX, 43(1), 2000, pp. 15-24

Authors: Lewin, G Schaeffer, C Hocquemiller, R Jacoby, E Leonce, S Pierre, A Atassi, G
Citation: G. Lewin et al., Access to new cytotoxic bisindole alkaloids by a modified borch reductive amination process, HETEROCYCLE, 53(11), 2000, pp. 2353

Authors: Ghirtis, K Pouli, N Marakos, P Skaltsounis, AL Leonce, S Caignard, DH Atassi, G
Citation: K. Ghirtis et al., Synthesis and conformational analysis of some new pyrano[2,3-c]xanthen-7-one and pyrano[3,2-b]xanthen-6-one derivatives with cytotoxic activity, HETEROCYCLE, 53(1), 2000, pp. 93-106

Authors: Langer, I Vertongen, P Perret, J Fontaine, J Atassi, G Robberecht, P
Citation: I. Langer et al., Expression of vascular endothelial growth factor (VEGF) and VEGF receptorsin human neuroblastomas, MED PED ONC, 34(6), 2000, pp. 386-393

Authors: Costes, N Le Deit, H Michel, S Tillequin, F Koch, M Pfeiffer, B Renard, P Leonce, S Guilbaud, N Kraus-Berthier, L Pierre, A Atassi, G
Citation: N. Costes et al., Synthesis and cytotoxic and antitumor activity of benzo[b]pyrano[3,2-h]acridin-7-one analogues of acronycine, J MED CHEM, 43(12), 2000, pp. 2395-2402

Authors: Kostakis, I Ghirtis, K Pouli, N Marakos, P Alexios-Leandros, S Leonce, S Caignard, DH Atassi, G
Citation: I. Kostakis et al., Synthesis and cytotoxic activity of 2-dialkylaminoethylamino substituted xanthenone and thioxanthenone derivatives, FARMACO, 55(6-7), 2000, pp. 455-460

Authors: Langer, I Atassi, G Robberecht, P Resibois, A
Citation: I. Langer et al., Eriochrome Black T inhibits endothelial cell growth through S-phase blockade, EUR J PHARM, 399(2-3), 2000, pp. 85-90

Authors: Aligiannis, N Pouli, N Marakos, P Mitaku, S Skaltsounis, AL Leonce, S Pierre, A Atassi, G
Citation: N. Aligiannis et al., Design, synthesis and biological activity of 7-O-(4-O-acetyl-3-iodo-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)daunomycinone and 7-O-(3-chloro-2,3,6-trideoxy-4-O-propanoyl-alpha-L-lyxo-hexopyranosyl)daunomycinone, CHEM PHARM, 48(1), 2000, pp. 150-153

Authors: Burbridge, MF Kraus-Berthier, L Naze, M Pierre, A Atassi, G Guilbaud, N
Citation: Mf. Burbridge et al., Biological and pharmacological characterisation of three models of human ovarian carcinoma established in nude mice: Use of the CA125 tumour marker to predict antitumour activity, INT J ONCOL, 15(6), 1999, pp. 1155-1162
Risultati: 1-25 | 26-31